CXCL9 and neoplasm: In vivo DC trafficking studies reveal that IT CXCL9/10-DC vaccines, although short-lived, increased the levels of CXCL9/10 within the TME and induced rapid infiltration of endogenous DCs and T cells into the tumor (Figure S3).